{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T03:09:52Z","timestamp":1771643392974,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":2928,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1038\/mt.2008.160","type":"journal-article","created":{"date-parts":[[2008,8,7]],"date-time":"2008-08-07T11:30:34Z","timestamp":1218108634000},"page":"1681-1687","source":"Crossref","is-referenced-by-count":24,"title":["Dual Therapeutic Effects of Interferon-\u03b1 Gene Therapy in a Rat Hepatocellular Carcinoma Model With Liver Cirrhosis"],"prefix":"10.1016","volume":"16","author":[{"given":"Kai-Wen","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Chi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Feng","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Huang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lih-Hwa","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2008.160_bib1","series-title":"Cancer: Principles and Practice of Oncology","first-page":"1162","article-title":"Cancers of the liver","author":"Carr","year":"2001"},{"key":"10.1038\/mt.2008.160_bib2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bpg.2006.07.002","article-title":"Hepatocellular carcinoma development in cirrhosis","volume":"21","author":"Okuda","year":"2007","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1038\/mt.2008.160_bib3","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/hep.510310310","article-title":"Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene","volume":"31","author":"Mohr","year":"2000","journal-title":"Hepatology"},{"key":"10.1038\/mt.2008.160_bib4","first-page":"7563","article-title":"Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma","volume":"61","author":"Tatsumi","year":"2001","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2008.160_bib5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/(SICI)1097-0215(19990531)81:5<813::AID-IJC24>3.0.CO;2-I","article-title":"Role of NK and T cells in IL-12-induced anti-tumor response against hepatic colon carcinoma","volume":"81","author":"Pham-Nguyen","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1038\/mt.2008.160_bib6","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.4049\/jimmunol.173.10.6025","article-title":"The immunization site of cytokine-secreting tumor cell vaccines influences the trafficking of tumor-specific T lymphocytes and antitumor efficacy against regional tumors","volume":"173","author":"Chang","year":"2004","journal-title":"J Immunol"},{"key":"10.1038\/mt.2008.160_bib7","first-page":"702","article-title":"Presence of alpha-fetoprotein-positive cells in hepatocellular foci and microcarcinomas induced by single injections of diethylnitrosamine in infant mice","volume":"43","author":"Koen","year":"1983","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2008.160_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1126\/science.152.3718.83","article-title":"Liver carcinogenesis by diethylnitrosamine in the rat","volume":"152","author":"Rajewsky","year":"1966","journal-title":"Science"},{"key":"10.1038\/mt.2008.160_bib9","first-page":"6452","article-title":"Dose and time relationships for tumor induction in the liver and esophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine","volume":"51","author":"Peto","year":"1991","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2008.160_bib10","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/carcin\/20.8.1541","article-title":"Effect of nodularin on the expression of glutathione S-transferase placental form and proliferating cell nuclear antigen in N-nitrosodiethylamine initiated hepatocarcinogenesis in the male Fischer 344 rat","volume":"20","author":"Song","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1038\/mt.2008.160_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/mc.1022","volume":"30","author":"Park","year":"2001","journal-title":"Mol Carcinog"},{"key":"10.1038\/mt.2008.160_bib12","first-page":"1112","article-title":"Persistence of resistant putative preneoplastic hepatocytes induced by N-nitrosodiethylamine or N-methyl-N-nitrosourea","volume":"40","author":"Solt","year":"1980","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2008.160_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/hep.21445","article-title":"Hepatitis B virus promotes hepatocarcinogenesis in transgenic mice","volume":"45","author":"Zheng","year":"2007","journal-title":"Hepatology"},{"key":"10.1038\/mt.2008.160_bib14","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","article-title":"Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury","volume":"275","author":"Friedman","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2008.160_bib15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/carcin\/bgh037","article-title":"Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma","volume":"25","author":"Yeh","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1038\/mt.2008.160_bib16","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0016-5085(82)80126-1","article-title":"High yield micronodular cirrhosis in the rat","volume":"83","author":"Proctor","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1038\/mt.2008.160_bib17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/jhep.2001.27949","article-title":"Adenosine reverses a preestablished CCl4-induced micronodular cirrhosis through enhancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats","volume":"34","author":"Hernandez-Munoz","year":"2001","journal-title":"Hepatology"},{"key":"10.1038\/mt.2008.160_bib18","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1053\/j.gastro.2003.12.045","article-title":"Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis","volume":"126","author":"Siller-Lopez","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1038\/mt.2008.160_bib19","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jhep.2006.07.030","article-title":"Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis","volume":"45","author":"Neef","year":"2006","journal-title":"J Hepato l"},{"key":"10.1038\/mt.2008.160_bib20","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1023\/A:1026601814082","article-title":"Morphological and biochemical effects of a low ethanol dose on rat liver regeneration: role of route and timing of administration","volume":"44","author":"Morales-Gonzalez","year":"1999","journal-title":"Dig Dis Sci"},{"key":"10.1038\/mt.2008.160_bib21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00007890-198810000-00007","article-title":"Reliable indices for the determination of viability of grafted liver immediately after orthotopic transplantation. Bile flow rate and cellular adenosine triphosphate level","volume":"46","author":"Sumimoto","year":"1988","journal-title":"Transplantation"},{"key":"10.1038\/mt.2008.160_bib22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.20538","article-title":"Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis","volume":"41","author":"Schiffer","year":"2005","journal-title":"Hepatology"},{"key":"10.1038\/mt.2008.160_bib23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1349-7006.2007.00408.x","article-title":"Local interferon-alpha gene therapy elicits systemic immunity in a syngeneic pancreatic cancer model in hamster","volume":"98","author":"Hara","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1038\/mt.2008.160_bib24","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1089\/hum.2005.16.957","article-title":"Interferon-alpha gene therapy by lentiviral vectors contrasts ovarian cancer growth through angiogenesis inhibition","volume":"16","author":"Indraccolo","year":"2005","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2008.160_bib25","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/hep.1840380415","article-title":"Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice","volume":"38","author":"Inagaki","year":"2003","journal-title":"Hepatology"},{"key":"10.1038\/mt.2008.160_bib26","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.gt.3301949","article-title":"Adenovirus-mediated gene transfer of interferon alpha improves dimethylnitrosamine-induced liver cirrhosis in rat model","volume":"10","author":"Suzuki","year":"2003","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2008.160_bib27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1478-3231.2006.01424.x","article-title":"New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system","volume":"27","author":"Berasain","year":"2007","journal-title":"Liver Int"},{"key":"10.1038\/mt.2008.160_bib28","doi-asserted-by":"crossref","first-page":"121S","DOI":"10.1097\/01.alc.0000189284.98684.22","article-title":"Anti- TGF-beta strategies for the treatment of chronic liver disease","volume":"29","author":"Breitkopf","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1038\/mt.2008.160_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2006.08.021","article-title":"Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma","volume":"46","author":"Lin","year":"2007","journal-title":"J Hepatol"},{"key":"10.1038\/mt.2008.160_bib30","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/hep.510240405","article-title":"Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration","volume":"24","author":"Poynard","year":"1996","journal-title":"Hepatology"},{"key":"10.1038\/mt.2008.160_bib31","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","article-title":"Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ","volume":"117","author":"Iredale","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2008.160_bib32","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.biochi.2007.04.006","article-title":"Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use","volume":"89","author":"Ferrantini","year":"2007","journal-title":"Biochimie"},{"key":"10.1038\/mt.2008.160_bib33","first-page":"2489","article-title":"Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons","volume":"58","author":"Pfeffer","year":"1998","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2008.160_bib34","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1440-1746.2005.03901.x","article-title":"Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: emphasis on sampling variability","volume":"20","author":"Lee","year":"2005","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616320718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616320718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T14:07:09Z","timestamp":1588860429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616320718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1525001616320718"],"URL":"https:\/\/doi.org\/10.1038\/mt.2008.160","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}